Viking Therapeutics (VKTX) Misses Q2 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Doximity downgraded by BofA on AI investment concerns, margin pressure
• Palantir surges 4% on Nvidia sovereign AI pact as software beats semis